Immunotherapy for Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is characterized by extensive tumor heterogeneity at both the pathologic and molecular levels, particularly accelerated aggressiveness, and terrible metastasis. It is responsible for the increased mortality of breast cancer patients. Due to the negative expressio...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yifeng, Chen, Chuyang, Tao, Yi, Lin, Weifeng, Wang, Ping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705248/
https://www.ncbi.nlm.nih.gov/pubmed/34959285
http://dx.doi.org/10.3390/pharmaceutics13122003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8705248/
https://www.ncbi.nlm.nih.gov/pubmed/34959285
http://dx.doi.org/10.3390/pharmaceutics13122003

Ejemplares similares